Copenhagen, 17 March 2016 – Pursuant to the Danish Securities Trading Act, section 28a, Zealand discloses information on transactions with the company’s shares and related securities by executives and persons/companies closely related to them.
With reference to the above, Zealand announces that it has received information on the below transactions for disclosure.
| Name: | Martin Nicklasson |
| Reason: | Chairman, Board of Directors |
| Issuer: | Zealand Pharma A/S |
| Designation: | Shares |
| ISIN Code: | DK0060257814 |
| Transaction: | Purchase of shares |
| Trading Date: | 16 March 2016 |
| Market: | Nasdaq Copenhagen |
| Number: | 1,000 |
| Price: | DKK 116.50 |
| Total value: | DKK 116,500.00 |
